SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.

Koenen R.; Fowler A.; Gupta A.; Hilbert J.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.

【24h】

SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.

机译：BI 1021958（一种新的CRTH2拮抗剂）在健康男性志愿者中的单剂量口服剂量的安全性，耐受性，药代动力学和药物动力学。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2016年第1期|共1页
作者
Koenen R.; Fowler A.; Gupta A.; Hilbert J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS. [J] . Koenen R., Fowler A., Gupta A., Clinical Pharmacology and Therapeutics . 2016,第Suppla1期

机译：BI 1021958（一种新的CRTH2拮抗剂）在健康男性志愿者中的单剂量口服剂量的安全性，耐受性，药代动力学和药物动力学。
2. SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY CHINESE AND JAPANESE MALES. [J] . Jang I., Kim J., Koenen R., Clinical Pharmacology and Therapeutics . 2016,第Suppla1期

机译：BI 1021958（一种新型CRTH2拮抗剂）在中国健康人群和日本人中的安全性，耐受性，药代动力学和药代动力学。
3. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma [J] . Fowler Andy, Koenen Ruediger, Hilbert James, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2017,第11期

机译：新型CRTH2对拮抗剂BI 1021958在健康男性和女性和女性中的单口服剂量下的新型CRTH2拮抗剂BI 1021958的安全性，耐受性，药代动力学和药效学，具有良好控制的哮喘
4. Safety, tolerability, pharmacodynamics and pharmacokinetics following single subcutaneous dosesof a teverelix depot formulation in healthy male volunteers [C] . C. MacLean, F. Larsen, R. Piechatzek, Annual meeting exposition of the Controlled Release Society . 2005

机译：在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性，耐受性，药效动力学和药代动力学
5. Pharmacokinetics, tissue depletion, target animal safety and live animal swab test accuracy after administration of long-acting oxytetracycline at double the label dose in healthy calves. [D] . TerHune, Terry Norman. 1988

机译：在健康小牛中，以双倍剂量服用长效土霉素后，药代动力学，组织耗竭，目标动物安全性和活体拭子测试准确性。
6. Safety tolerability pharmacokinetics and pharmacodynamics of single oral doses of BI 187004 an inhibitor of 11beta-hydroxysteroid dehydrogenase-1 in healthy male volunteers with overweight or obesity [O] . Susanna Bianzano, Tim Heise, Arvid Jungnik, 2021

机译：单次口服剂量乳头剂量的安全性耐受性药代动力学和药效学11beta-羟类脱氢酶-1的抑制剂具有超重或肥胖的健康男性志愿者
7. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of Bi 187004, an Inhibitor of 11beta-hydroxysteroid Dehydrogenase-1, in Healthy Male Volunteers With Overweight or Obesity [O] . Susanna Bianzano, Tim Heise, Arvid Jungnik, 2020

机译：单次口服剂量，乳头剂量的安全性，耐受性，药代动力学和药效学，11beta-羟类脱氢酶-1的抑制剂，具有超重或肥胖的健康男性志愿者

SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.

著录项

相似文献

相关主题

期刊订阅